Concepedia

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

Paul M. Ridker, Douglas E. Vaughan, JE Manson, C H Hennekens, MJ Stampfer

The Lancet · 1993 · 585 citations · 20 references

Concepts

MedicineCardiologyInternal MedicineClinical CardiologyInterventional CardiologyAcute Coronary SyndromesCardiovascular DiseaseCardiovascular PathophysiologyCoronary Artery DiseaseIschemic Heart DiseaseMyocardial Infarction ComplicationsFibrinolytic RegulationInflammatory Cardiac BiomarkersPlasminogen Activator ReleasePlasminogen ActivatorsPost-myocardial Infarction Complications

References

20

The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes

Valentı́n Fuster · New England Journal of Medicine · 1992 · 3.7K citations

Medicine, Cardiology, Nuclear Medicine +12

Final Report on the Aspirin Component of the Ongoing Physicians' Health Study

New England Journal of Medicine · 1989 · 2.3K citations

Medicine, Pharmacology, Pharmacotherapy +16

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

Anders Hamsten, Göran Walldius, Alfred Szamosi et al. · The Lancet · 1987 · 1.5K citations

Medicine, Cardiology, Clinical Cardiology +11

Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction

Anders Hamsten, Björn Wiman, Ulf dé Fairé et al. · New England Journal of Medicine · 1985 · 1.4K citations

Medicine, Cardiology, Clinical Cardiology +10

Plasminogen activator inhibitors

E.D. Sprengers, C Kluft · Blood · 1987 · 930 citations · Full text

Life Sciences, Pharmacology, Enzymology +12